NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Hugo Biotech

Hugo Biotech

Private
BeijingHealthcare & Life Scienceshttps://www.hugobiotech.com/

Last Round

Grant

Dec 1, 2024

Total Funding Raised

$127.2M

Company Overview

Hugo Biotech is a biotechnology company that specializes in high-throughput microbial sequencing technology and microbial genome big data analysis for the rapid identification of pathogenic microorganisms in clinical samples.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Biotech Equipment, Healthcare Analytics

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales, Subscription SaaS

AI Layer

Application

Keywords

metagenomic next-generation sequencingmNGSpathogen identificationclinical diagnosticsprecision medicinemicrobial sequencingAI diagnosticslab automationnucleic acid extractioncloud-based bioinformaticsinfectious disease testingpathogen detectionmolecular diagnosticsdigital pathologymedtech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Hugo Biotech Comps

Public and private peers based on sector, stage, and business model.

Hugo Biotech comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Hugo Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 1, 2024
GrantNov 1, 2024
Series CJan 21, 2022
Series BJul 20, 2021
Series ASep 28, 2020
Series A Extension
Jun 29, 2020

Key People

Founding team and executive leadership

Han Xia

CEO & founder at HugoBiotech

Founding Team

Hugo Biotech Investors

Notable investors and investment history

Hugo Biotech investors
InvestorRounds
CD Capital Asset ManagementSeries A
Lapam CapitalSeries A
Northern Light Venture CapitalSeries A, Seed
LYFE CapitalSeries C, Series B
Gates FoundationGrant
The Bill & Melinda Gates Foundation TrustGrant
Sinovation VenturesSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 29, 2020

    $1.4M Series A Extension round completed.

Hugo Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Hugo Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Hugo Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersBeijing
Employee Range5
Year Founded2017
Last FundingDec 1, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.